Comparison of the analgesic effects of serratus anterior block and intercostal nerve block on thoracoscopic-assisted lobectomy: a prospective, randomized controlled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047941

Enrollment

Unknown

Registered

2021-06-28

Start date

2021-06-30

Completion date

Unknown

Last updated

2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Group 1:intercostal nerve block

Group 2:serratus anterior block

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years; 2. ASA classification I-III; 3. Patients with thoracoscopic lobe or wedge surgery.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to the drugs used in this study; 2. Those who have a history of chronic pain or who have used analgesic drugs within the past 3 months, and who are alcohol and drug addicts; 3. Severe liver and kidney dysfunction; 4. Those with abnormal coagulation function; 5. There is infection at the injection site; 6. Those who are mentally abnormal or unable to effectively communicate and cooperate to complete the VAS visual simulation pain assessment; 7. Those who will not use self-controlled analgesia equipment.

Design outcomes

Primary

Measure	Time frame
VAS pain score;	—

Secondary

Measure	Time frame
Pulmonary complications;Adverse reactions after surgery;Total postoperative analgesics;ICU stay time;The number of days in hospital;	—

Countries

China

Contacts

Public ContactLin Wenqian

Sun Yat-sen University Cancer Center

linwq@sysucc.org.cn+86 13825149286

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026